177Lu-PSMA-617
Novartis
['radio', 'ligand']
psma pet tumor-to-salivary glands ratio (psg score) to predict response to lu-177 psma radioligand therapy: an international multicenter retrospective study. presented by . #asco22 written coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #AUA22 #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology